- Home
- ALDX vs SUNS Comparison
ALDX vs SUNS Comparison
Compare ALDX & SUNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALDX
- SUNS
- Stock Information
- Founded
- ALDX 2004
- SUNS 2023
- Country
- ALDX United States
- SUNS United States
- Employees
- ALDX N/A
- SUNS N/A
- Industry
- ALDX Biotechnology: Pharmaceutical Preparations
- SUNS Real Estate Investment Trusts
- Sector
- ALDX Health Care
- SUNS Real Estate
- Exchange
- ALDX Nasdaq
- SUNS Nasdaq
- Market Cap
- ALDX 160.8M
- SUNS 142.3M
- IPO Year
- ALDX 2014
- SUNS N/A
- Fundamental
- Price
- ALDX $4.76
- SUNS $10.77
- Analyst Decision
- ALDX Strong Buy
- SUNS Strong Buy
- Analyst Count
- ALDX 2
- SUNS 3
- Target Price
- ALDX $9.50
- SUNS $13.67
- AVG Volume (30 Days)
- ALDX 1.2M
- SUNS 73.5K
- Earning Date
- ALDX 07-31-2025
- SUNS 08-07-2025
- Dividend Yield
- ALDX N/A
- SUNS 11.12%
- EPS Growth
- ALDX N/A
- SUNS N/A
- EPS
- ALDX N/A
- SUNS 1.02
- Revenue
- ALDX N/A
- SUNS $13,066,680.00
- Revenue This Year
- ALDX N/A
- SUNS $148.89
- Revenue Next Year
- ALDX N/A
- SUNS $43.47
- P/E Ratio
- ALDX N/A
- SUNS $10.58
- Revenue Growth
- ALDX N/A
- SUNS 1342.10
- 52 Week Low
- ALDX $1.14
- SUNS $7.80
- 52 Week High
- ALDX $7.20
- SUNS $15.74
- Technical
- Relative Strength Index (RSI)
- ALDX 78.74
- SUNS N/A
- Support Level
- ALDX $4.12
- SUNS N/A
- Resistance Level
- ALDX $4.60
- SUNS N/A
- Average True Range (ATR)
- ALDX 0.29
- SUNS 0.00
- MACD
- ALDX 0.08
- SUNS 0.00
- Stochastic Oscillator
- ALDX 90.91
- SUNS 0.00
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.
About SUNS Sunrise Realty Trust Inc. Common Stock
Sunrise Realty Trust Inc is a real estate investment trust company. It is focus on originating CRE debt investments and providing capital to high-quality borrowers and sponsors with transitional business plans collateralized by CRE assets with opportunities for near-term value creation, as well as recapitalization opportunities. It intends to create a diversified investment portfolio, targeting investments in senior mortgage loans, mezzanine loans, whole loans, B-notes, CMBS and debt-like preferred equity securities across CRE asset classes and investment mix to include high quality multi-family, condominiums, retail, office, hospitality, industrial, mixed use and specialty-use real estate.